CyMedica Orthopedics
- Industry
- Medical Devices
- Founded Year
- 2013
- Headquarters
- 19120 N. Pima Rd, Suite 135, Scottsdale, AZ 85255, USA
- Employee Count
- 0
Key People
- Robert J. Morocco - President & CEO
- D. Ronald Yagoda - Co-Founder
- Struan Coleman - Co-Founder
- Pete Kilpatrick - Vice President of Operations and Compliance
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with backgrounds in medical device innovation and operations.
The presence of multiple successful MedTech entrepreneurs in the leadership team suggests a strong foundation for strategic decision-making and product development.
- Clinical Need
-
Aspect: Very Strong
Summary: The e-vive system addresses significant muscle atrophy issues in patients undergoing knee surgeries.
Muscle atrophy is a common and challenging issue following knee surgeries. The e-vive system's focus on this problem indicates a strong alignment with clinical needs.
- Competition
-
Aspect: Somewhat crowded
Summary: The market for post-operative rehabilitation devices has several players, but e-vive's unique features provide differentiation.
The presence of multiple competitors in the rehabilitation device market poses challenges, but e-vive's app-controlled muscle stimulation and patient engagement features set it apart.
- Technical Challenge
-
Aspect: Predictable
Summary: The technology behind e-vive is well-established, with predictable development pathways.
The use of neuromuscular electrical stimulation in rehabilitation is a known technology, reducing the risk of unforeseen technical challenges.
- Patent
-
Aspect: Strong
Summary: CyMedica holds patents for its muscle activation and patient engagement systems.
Holding patents for key technologies protects the company's innovations and can deter competitors from entering the same space.
- Financing
-
Aspect: Medium
Summary: The company has secured funding but may require additional capital for expansion.
While initial funding has been obtained, scaling production and marketing efforts typically require substantial capital, which may necessitate further investment.
- Regulatory
-
Aspect: 510k/PMA
Summary: The e-vive system has received FDA 510(k) clearance.
Achieving FDA clearance is crucial for market entry, but maintaining compliance and obtaining approvals in other markets are ongoing challenges.
Opportunity Rollup
- Odds of Success
- 3.85
- Peak Market Share
- 5.2
- Segment CAGR
- 3.0%
- Market Segment
- Orthopedic Devices
- Market Sub Segment
- Post-Operative Rehabilitation Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.26 |
| 2 | 0.78 |
| 3 | 1.82 |
| 4 | 3.64 |
| 5 | 5.20 |
Key Takeaway
CyMedica Orthopedics, now rebranded as Motive Health, offers a unique solution in the post-operative rehabilitation market with its e-vive system, addressing a significant clinical need with innovative technology.